Methyl Cyclohexane Market Global Report 2026

The methyl cyclohexane market size has grown strongly in recent years. It will grow from $1.4 billion in 2025 to $1.5 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increasing demand from chemical manufacturing industries, rising adoption as a solvent in industrial processes, growing utilization in rubber and coating applications, expanding petrochemical production activities, and increasing demand for organic synthesis materials.

The methyl cyclohexane market size is expected to see strong growth in the next few years. It will grow to $1.9 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth during the forecast period can be attributed to growing adoption of hydrogen carrier technologies, rising investments in hydrogen energy infrastructure, increasing demand for high-purity methyl cyclohexane grades, expanding applications in clean energy storage systems, and growing chemical industry development across emerging economies. Major trends in the forecast period include increasing demand for hydrogen carrier applications, growing adoption of methyl cyclohexane in organic synthesis, rising utilization in advanced chemical manufacturing processes, increasing demand for high-purity chemical solvents, and growing development of hydrogen storage and transportation solutions.

The rising demand from pharmaceutical manufacturing is expected to drive the growth of the methyl cyclohexane market going forward. Pharmaceutical manufacturing refers to the industrial process of researching, developing, producing, formulating, packaging, and quality-testing pharmaceutical products to ensure their safety, effectiveness, and compliance with regulatory standards. Demand in pharmaceutical manufacturing is increasing due to the growing production of medicines, as expanding healthcare requirements and the rising prevalence of chronic diseases require greater volumes of pharmaceutical products. Methyl cyclohexane serves as an effective solvent and chemical intermediate in pharmaceutical manufacturing, supporting the synthesis, purification, and processing of active pharmaceutical ingredients and other pharmaceutical compounds. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing the pharmaceutical industry in Europe, total pharmaceutical production in Europe reached €390.00 billion ($422,803 million) in 2023, compared with €363.30 billion ($393,857 million) in 2022. Therefore, the rising demand from pharmaceutical manufacturing is driving the growth of the methyl cyclohexane market.

Major companies operating in the methyl cyclohexane market are focusing on advancing methyl cyclohexane (MCH) dehydrogenation technologies to enable efficient hydrogen storage and long-distance transportation, supporting the commercialization of hydrogen supply chains. Methyl cyclohexane (MCH) dehydrogenation technology is a process that releases hydrogen gas from MCH, allowing it to function as a liquid organic hydrogen carrier (LOHC) for safe and efficient hydrogen transportation. For instance, in May 2025, Honeywell International Inc., a US-based industrial technology company, announced that its Honeywell UOP MCH dehydrogenation technology had been selected by ENEOS for the world's first commercial-scale hydrogen supply chain using MCH. The project integrates hydrogen production, storage, transportation, distribution, and material recovery, enabling efficient hydrogen delivery while recycling toluene for reuse. The technology strengthens the commercial viability of hydrogen transportation by supporting safe, cost-effective, and long-distance hydrogen logistics through the LOHC pathway.

In February 2024, Honeywell International Inc., a US-based technology and manufacturing company, partnered with ENEOS Corporation to begin basic engineering for the world’s first commercial-scale liquid organic hydrogen carrier (LOHC) project using Honeywell UOP’s methylcyclohexane (MCH) dehydrogenation technology. Through this partnership, the companies aim to establish an efficient and cost-effective hydrogen supply chain that enables the safe transportation and storage of hydrogen over long distances. ENEOS Corporation is a Japan-based energy company specializing in crude oil exploration.

Major companies operating in the methyl cyclohexane market are ExxonMobil Corporation, China Petroleum & Chemical Corporation, Shell plc, ENEOS Corporation, Idemitsu Kosan Co. Ltd., INEOS Group Limited, Thermo Fisher Scientific Inc., Merck KGaA, Chevron Phillips Chemical Company LLC, Maruzen Petrochemical Co. Ltd., Tokyo Chemical Industry Co. Ltd., BLD Pharmatech Inc., Spectrum Chemical Mfg. Corp., Apollo Scientific Ltd., Sankyo Chemical Co. Ltd., J&K Scientific LLC, Shanghai Macklin Biochemical Co. Ltd., Santa Cruz Biotechnology Inc., Oakwood Products Inc., Chem-Impex International Inc., Sisco Research Laboratories Pvt. Ltd., Central Drug House (P) Ltd., Henan GP Chemicals Co. Ltd., Haihang Industry Co. Ltd., Loba Chemie Pvt. Ltd., Anhui Fulltime Specialized Solvent & Reagent Co. Ltd., Changzhou Xiaqing Chemical Co. Ltd., Alfa Chemistry Inc., Alpha Chemika.

Asia-Pacific was the dominant region in the methyl cyclohexane market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the methyl cyclohexane market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the methyl cyclohexane market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.